静脉注射
转移
小RNA
生物
癌症研究
细胞外基质
细胞迁移
血管生成
基质金属蛋白酶
肿瘤进展
原发性肿瘤
上皮-间质转换
细胞
癌症
细胞生物学
基因
遗传学
作者
Tomasz M. Grzywa,Klaudia Klicka,Paweł Włodarski
出处
期刊:Cancers
[MDPI AG]
日期:2020-12-10
卷期号:12 (12): 3709-3709
被引量:24
标识
DOI:10.3390/cancers12123709
摘要
Tumor cell invasiveness and metastasis are the main causes of mortality in cancer. Tumor progression is composed of many steps, including primary tumor growth, local invasion, intravasation, survival in the circulation, pre-metastatic niche formation, and metastasis. All these steps are strictly controlled by microRNAs (miRNAs), small non-coding RNA that regulate gene expression at the post-transcriptional level. miRNAs can act as oncomiRs that promote tumor cell invasion and metastasis or as tumor suppressor miRNAs that inhibit tumor progression. These miRNAs regulate the actin cytoskeleton, the expression of extracellular matrix (ECM) receptors including integrins and ECM-remodeling enzymes comprising matrix metalloproteinases (MMPs), and regulate epithelial–mesenchymal transition (EMT), hence modulating cell migration and invasiveness. Moreover, miRNAs regulate angiogenesis, the formation of a pre-metastatic niche, and metastasis. Thus, miRNAs are biomarkers of metastases as well as promising targets of therapy. In this review, we comprehensively describe the role of various miRNAs in tumor cell migration, invasion, and metastasis.
科研通智能强力驱动
Strongly Powered by AbleSci AI